The first group include BRAF (most often BRAFV600E) mutant melanomas (~50%)6, the second group are NRASQ61L/R mutant melanomas (15–20%), the third group are NF1 mutant melanomas (15%), and the fourth group are triple wild-type melanomas (15–20%)7. This evidence concerns the gene NF1 and melanoma.